Prof. Khaled S Allemailem started his career as a teacher in the Ministry of Education in 2003. He joined College of Applied Medical Science, Qassim University as a Teaching Assistant in 2007. He was awarded a PhD degree in Medical Microbiology at RMIT University, Australia. He also obtained an MSc in Laboratory Medicine and a Graduate Diploma in Biotechnology at RMIT University, Australia. He completed his BSc in Medical Microbiology at College of Science, King Saud University. Currently, he is working as a Professor in Medical & Molecular Microbiology and as a Medical Microbiology Consultant in Qassim University Medical City. Prof. Khaled has participated in many national and international conferences, including CHRO 2013, Scotland, and CHRO 2015, New Zealand. He also joined the Australian Society for Microbiology annual meetings held in 2013 and 2019 in Australia. He was the 1st Poster Winner at Medlab Middle East 2019 held in Dubai, UAE. He also participated at Medlab Asia Congress 2022, Thailand as a speaker. Prof. Khaled has published more than 130 scientific papers in many peer-reviewed journals of international repute. In addition, he holds a patent titled "A novel polytherapeutic formulation with anti-asthmatic potential" granted by the Deutsches Patent und Markenamt (German Patent and Trade Mark Office) in October 2022. He is also recognized as one of the top 2% most-cited scientists worldwide (2023 & 2024), according to Stanford University, USA.